Literature DB >> 29751149

An inhibitor of soluble epoxide hydrolase ameliorates diabetes-induced learning and memory impairment in rats.

Nathani Minaz1, Rema Razdan1, Bruce D Hammock2, Sumanta Kumar Goswami3.   

Abstract

BACKGROUND: Pharmacological inhibition of soluble epoxide hydrolase (sEH) enhances the synaptic function in the CNS and has a protective role in cognitive decline. We hypothesized that the sEH inhibitor TPPU might prevent the diabetes-induced decline in learning and memory which is associated with an alteration in the level of neurotransmitters and oxidative stress.
METHODS: Type 1 diabetes was induced in rats and the animals were treated with TPPU for 8 weeks. The learning and memory functions were assessed by the Barnes maze and a step-down test. Indicators of oxidative stress, levels of neurotransmitters, and activity of acetylcholinesterase were measured in the discrete regions of the brain.
RESULTS: Our results revealed that treatment with TPPU significantly improves learning and memory performance in diabetic rats along with decreasing the level of blood sugar. Moreover, treatment with TPPU significantly prevented the diabetes-induced alteration in levels of neurotransmitters, the activity of acetylcholinesterase and preserved anti-oxidant defence system.
CONCLUSION: Inhibition of the sEH alleviates diabetes-induced decline in learning and memory.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognitive impairment; Diabetes; NE and DA; Neurotransmitter GABA; Oxidative stress markers GSH and MDA; sEH inhibitor TPPU

Mesh:

Substances:

Year:  2018        PMID: 29751149      PMCID: PMC6402559          DOI: 10.1016/j.prostaglandins.2018.05.004

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  6 in total

Review 1.  Function of the GABAergic System in Diabetic Encephalopathy.

Authors:  Hongli Zhou; Zhili Rao; Zuo Zhang; Jiyin Zhou
Journal:  Cell Mol Neurobiol       Date:  2022-04-23       Impact factor: 5.046

2.  1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells.

Authors:  Zhibin Liang; Bei Zhang; Meng Xu; Christophe Morisseau; Sung Hee Hwang; Bruce D Hammock; Qing X Li
Journal:  ACS Chem Neurosci       Date:  2019-08-19       Impact factor: 4.418

3.  Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer's Disease-Like Complications of Diabetes.

Authors:  Rohit Pardeshi; Nityanand Bolshette; Kundlik Gadhave; Mohammad Arfeen; Sahabuddin Ahmed; Rohitash Jamwal; Bruce D Hammock; Mangala Lahkar; Sumanta Kumar Goswami
Journal:  Front Pharmacol       Date:  2019-04-24       Impact factor: 5.810

4.  Impact of diabetes on male sexual function in streptozotocin-induced diabetic rats: Protective role of soluble epoxide hydrolase inhibitor.

Authors:  Nathani Minaz; Rema Razdan; Bruce D Hammock; Somdutt Mujwar; Sumanta Kumar Goswami
Journal:  Biomed Pharmacother       Date:  2019-05-15       Impact factor: 6.529

5.  Inhibition of Soluble Epoxide Hydrolase Is Protective against the Multiomic Effects of a High Glycemic Diet on Brain Microvascular Inflammation and Cognitive Dysfunction.

Authors:  Saivageethi Nuthikattu; Dragan Milenkovic; Jennifer E Norman; John Rutledge; Amparo Villablanca
Journal:  Nutrients       Date:  2021-11-01       Impact factor: 5.717

6.  Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathology.

Authors:  Frances M Potjewyd; Joel K Annor-Gyamfi; Jeffrey Aubé; Shaoyou Chu; Ivie L Conlon; Kevin J Frankowski; Shiva K R Guduru; Brian P Hardy; Megan D Hopkins; Chizuru Kinoshita; Dmitri B Kireev; Emily R Mason; Charles T Moerk; Felix Nwogbo; Kenneth H Pearce; Timothy I Richardson; David A Rogers; Disha M Soni; Michael Stashko; Xiaodong Wang; Carrow Wells; Timothy M Willson; Stephen V Frye; Jessica E Young; Alison D Axtman
Journal:  Alzheimers Dement (N Y)       Date:  2022-04-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.